CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
Mindshift CBT +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04841603
NCT04841603N/ACompleted
CompareCT.gov

Brief Digital CBT for Mood and Anxiety Symptoms in Acute Psychiatric Inpatients: a Randomized Feasibility Trial

Centre for Addiction and Mental Health·interventional·Posted Apr 12, 2021·Updated Jul 27, 2021

In Brief

A clinical study evaluating Mindshift CBT and Treatment as Usual for Anxiety and 6 related conditions. Completed, enrolled 24 participants across 1 site.

Detailed Summary

A randomized control trial examining the feasibility, acceptability, and preliminary efficacy of providing access to the MindShift CBT mobile app via tablet for acute psychiatric inpatients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnxiety, Depressive Symptoms, Distress, Emotional, Anxiety and Fear, Anxiety State, Mental Disorders, Severe, Psychiatric Hospitalization
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedApr 12, 2021
Enrollment StartApr 12, 2021
Primary CompletionMay 11, 2021
TodayJul 2, 2026
Enrollment to primary: 29 daysPosted 5.2 years ago

Interventions

Mindshift CBTdevice

A tablet with the Mindshift CBT app installed. Mindshift CBT is a free, evidence based app developed by Anxiety Canada, designed to help users reduce symptoms of anxiety and distress.

Treatment as Usualdevice

Treatment as usual. A tablet identical to the intervention group, but without the Mindshift CBT app is available for patients to use during their inpatient stay.